Sana Biotechnology results from the phase 1 study using SC291 for the treatment of patients with SLE are expected in 2025.

Nov. 21, 2024 — Researchers have reported the discovery of a previously unknown compound in chloraminated drinking water. Inorganic chloramines are commonly used to disinfect drinking water to ...

The U.S. Food and Drug Administration gave SC291, a CD19-directed allogeneic CAR T cell therapy developed using Sana's hypoimmune platform, fast track designation, a process designed to facilitate the ...

Fast Track designation is designed to expedite clinical development and regulatory review timelinesEnrolling patients in the GLEAM trial for ...

NHL Vancouver Canucks and Fortinet ® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced that Fortinet has become the new Preferred ...

Sana Biotechnology (SANA) announced that the U.S. Food and Drug Administration granted Fast Track designation for SC291 in relapsed/refractory systemic lupus erythematosus, which includes extrarenal ...

Stock up on shapewear, loungewear, holiday gifts, and more from Kim Kardashian's SKIMS Black Friday Sale. This is the brand's first-ever sitewide sale, so these styles are bound to sell out fast ...

November 20, 2024 • A deep sea oarfish washed up in Southern California. Some accounts say Japanese folklore saw it a bad omen, while others say the fish were seen as saviors.

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by inflammation and tissue damage across multiple organ systems, such as the skin, joints, kidneys, heart, and brain.

Sana Biotechnology, Inc.'s stock has dropped, but with pipeline focus and upcoming trial data, its prospects remain mixed ...

Pomerantz LLP is investigating claims on behalf of investors of  Sana Biotechnology, Inc. ("Sana" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...